HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
A woman holds a pill up to a smartphone and prepares to take the pill.

NCATS Small Business Award Seeds App Development

NCATS-funded team creates artificial intelligence for mobile devices to improve medication adherence.

Monica Kasbekar, Michael Gormally and Ian Goldlust

Training the Next Generation

Doctoral students use NCATS resources to investigate promising disease therapies for cancers and tuberculosis.

Ali Torkamani and Galina Erikson

Uncovering the Genetics of Healthy Aging

CTSA Program-funded researchers are studying natural disease resistance to identify therapeutic targets that help prevent or treat age-associated diseases.

Teddy Perron has been diagnosed with a mitochondrial disease.

Rare Disease Patient Profiles

Hear rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope.

NCATS e-newsletter displayed on a tablet

July E-Newsletter Now Available

Learn about NCATS’ new rare diseases patient video series, a possible treatment for Parkinson’s and Gaucher, a CTSA Program training success, and more.

NCATS Small Business Award Seeds App Development

NCATS-funded team creates artificial intelligence for mobile devices to improve medication adherence.

A woman holds a pill up to a smartphone and prepares to take the pill.

Training the Next Generation

Doctoral students use NCATS resources to investigate promising disease therapies for cancers and tuberculosis.

Monica Kasbekar, Michael Gormally and Ian Goldlust

Uncovering the Genetics of Healthy Aging

CTSA Program-funded researchers are studying natural disease resistance to identify therapeutic targets that help prevent or treat age-associated diseases.

Ali Torkamani and Galina Erikson

Rare Disease Patient Profiles

Hear rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope.

Teddy Perron has been diagnosed with a mitochondrial disease.

July E-Newsletter Now Available

Learn about NCATS’ new rare diseases patient video series, a possible treatment for Parkinson’s and Gaucher, a CTSA Program training success, and more.

NCATS e-newsletter displayed on a tablet

More Center News

Ying LiangScholar Receives Grant
CTSA Program enables study of how a protein could prevent stem cell damage.

Juli Feigon and Jiansen JiangSeeing Clearly
CTSA Program support enables clearest-ever image of key enzyme in cancer, aging.

  • Facebook icon
  • Twitter icon
  • YouTube icon

Director's Corner

Watch a CTSA Program Video

NCATS CTSA Program Interview

Petra Kaufmann, M.D., M.Sc., director of the NCATS Office of Rare Diseases Research and Division of Clinical Innovation, discusses how CTSA Program support is speeding the translation of research discoveries into health benefits. View the video.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.